Sramana Mitra: Is there an online-offline data overlay as well? You’re not trying to map that customer to a real customer in retail to be able to market to that person? Florian Eggenschwiler: When you’re online, you don’t tend to be anonymous. In our basic setup, you’re an anonymous dot with attributes like gender. Sramana
Sramana Mitra: Who are the buyers? Florian Eggenschwiler: It’s usually the airports. There are a number of stakeholders involved that get access to the data. It’s usually the airport that we work with directly. There are also the landlords. They’re the ones that install hardware into the ceiling. They usually tend to be open with
A fascinating conversation about how Xovis is applying AI to modeling human behavior in public spaces. Sramana Mitra: Let’s start by giving our audience a bit of your background as well as the background of the company. Florian Eggenschwiler: I’m the Chief Product Officer at Xovis. Xovis is a Swiss-based company helping the world rethink
Sramana Mitra: You have chosen certain markets to go after. What’s happening in the broader ecosystem that you’re playing in with the same kinds of applications and use cases but in different geographies or maybe different use cases. Who is playing in your space that you’re watching from the corner of your eye? I’ve seen
Sramana Mitra: Talk about your business model. Your doctors are your end customers? Sungwon Lim: Yes. Sramana Mitra: Is it a subscription service or a diagnostic model? Sungwon Lim: We charge per service order. Our customers are hospitals and veterinarian oncologists. We sell our service to them and they add their own margin to the
Sramana Mitra: Bottomline is, you’re talking about narrowing the market down more and more to figure out where you want to penetrate the market and where you really want to build the business. Then there are sales channel issues. You have to put Salesforce going after each other’s markets. Let’s get to the technology side
Sramana Mitra: What is the dataset? Across all these categories, how many drugs and treatments are we talking about that you have modeled and have data for? Sungwon Lim: Our first service which we commercialized last year is for dog blood cancer. What we are trying to do is help doctors make decisions. The 16
Marc Vontobel: Without having very good positioning, we already created traction and signed some big deals with some Fortune 500 companies. That helped us find out the real use cases where we can have a real impact on the business. If you buy Starmind without having a clear use case in mind, you always depend